The latest news about Lumendi
A Randomized Prospective Study Evaluating Effectiveness Of A Double Balloon Endolumenal Platform For Colorectal EndoscopicSubmucosal Dissection
Endoscopic removal of colonic polyps and early cancers eliminates the need for surgical resection and possible temporary or permanent colostomy.
Lumendi Receives 510(k) Clearance for Two New Devices
Lumendi, LLC has received U.S. Food and Drug Administration (FDA) 510(k) clearance for DiLumen EZ¹, a single-use, disposable endotherapy device for endoscopic mucosal resections (EMR) and difficult colonoscopies.
Expansion of the Dilumen Platform
DiLumen EZ¹ The DiLumen EZ¹ is a variant of the DiLumen design, specially intended for the removal of complex polyps using the EMR* technique. Thanks to its unique balloon design,… Continue reading Expansion of the Dilumen Platform
30% of surgical interventions are unnesessary
Introducing EZ Glide in Europe
Many studies have documented that an endoscopic approach for ESD is a safer and less expensive alternative to removing these polyps, leading to fewer postoperative complications and shorter hospital stays.